Cannabinol modulates distinct endocannabinoid system elements and exerts anti-inflammatory effects Supports therapeutic potential of cannabinol for inflammatory skin diseases such as psoriasis, atopic ...
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Sep 3, 2015) - InMed Pharmaceuticals Inc. ("InMed" or "the Company") (CSE:IN)(OTCQB:IMLFF), a biopharmaceutical company specializing in the research and ...
Vancouver, British Columbia--(Newsfile Corp. - June 13, 2025) - InMed Pharmaceuticals Inc. (INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary ...
VANCOUVER, British Columbia, March 31, 2015 /PRNewswire/ -- InMed Pharmaceuticals Inc. ("InMed") (CSE: IN; OTCQB: IMLFF), a clinical stage biopharmaceutical company that specializes in developing ...
VANCOUVER, Jan. 21, 2020 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a clinical stage biopharmaceutical company developing medications targeting diseases with ...
VANCOUVER - InMed Pharmaceuticals Inc. (NASDAQ: INM), una empresa biotecnológica de pequeña capitalización con un valor de mercado de 2,21 millones de dólares, ha anunciado la selección de una ...
VANCOUVER, British Columbia, Dec. 12, 2022 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the pharmaceutical research, development and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results